Frontline_Plc grants synthetic options
Analysis based on 6 articles · First reported May 29, 2026 · Last updated May 29, 2026
The market impact is generally positive for Front line (disambiguation) as the granting of synthetic options to management and employees can align their interests with shareholder value, potentially boosting long-term performance. However, the dilution effect from future cash settlements could be a minor consideration.
Front line (disambiguation) announced the grant of 276,895 synthetic options to its management and employees. These options have a five-year term, expiring on May 29, 2031, and will vest over a three-year period. The exercise price is USD 36.8, which is the volume-weighted average price of the share over the last 30 days. The exercise price will be adjusted for any dividends distributed before exercise. Synthetic options granted to the CEO and CFO are capped at two times their annual base salary gain. The options will be cash-settled based on the difference between the market price and the exercise price at the time of exercise. This action was taken in accordance with the Company's synthetic option scheme.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard